{"id":1068106,"date":"2021-12-21T01:45:47","date_gmt":"2021-12-21T06:45:47","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/biodelivery-sciences-prevails-in-belbuca-anda-litigation-maintaining-patent-exclusivity-against-alvogen-until-2032\/"},"modified":"2024-08-18T11:42:57","modified_gmt":"2024-08-18T15:42:57","slug":"biodelivery-sciences-prevails-in-belbuca-anda-litigation-maintaining-patent-exclusivity-against-alvogen-until-2032","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/biodelivery-sciences-prevails-in-belbuca-anda-litigation-maintaining-patent-exclusivity-against-alvogen-until-2032.php","title":{"rendered":"BioDelivery Sciences Prevails in BELBUCA\u00ae ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032"},"content":{"rendered":"<p><![CDATA[RALEIGH, N.C., Dec.  20, 2021  (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc.\u00a0(NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that the U.S. District Court of Delaware has issued an opinion in favor of BDSI in the company\u2019s patent litigation against Alvogen Group, Inc. and its affiliates, who filed an Abbreviated New Drug Application (ANDA) for BDSI\u2019s BELBUCA\u00ae product on May 23, 2018. The opinion by the trial judge upholds the validity of claims in BDSI\u2019s patents 8,147,866 (the \u2018866 patent), which expires in 2027, and 9,901,539 (the \u2018539 patent), which expires in 2032. Alvogen conceded infringement of these claims. Accordingly, BDSI expects market exclusivity of BELBUCA against Alvogen until 2032.]]><\/p>\n<p>Continued here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/12\/20\/2355670\/0\/en\/BioDelivery-Sciences-Prevails-in-BELBUCA-ANDA-Litigation-Maintaining-Patent-Exclusivity-Against-Alvogen-Until-2032.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"BioDelivery Sciences Prevails in BELBUCA\u00ae ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032\">BioDelivery Sciences Prevails in BELBUCA\u00ae ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continued here: BioDelivery Sciences Prevails in BELBUCA\u00ae ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/biodelivery-sciences-prevails-in-belbuca-anda-litigation-maintaining-patent-exclusivity-against-alvogen-until-2032.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068106","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068106"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068106"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068106\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}